Hill, L. F., Turner, M. A., Lutsar, I., Heath, P. T., Hardy, P., Linsell, L., . . . Sharland, M. (2020). An optimised dosing regimen versus a standard dosing regimen of vancomycin for the treatment of late onset sepsis due to Gram-positive microorganisms in neonates and infants aged less than 90 days (NeoVanc): Study protocol for a randomised controlled trial. Trials.

Hill, Louise F., Mark A. Turner, Irja Lutsar, Paul T. Heath, Pollyanna Hardy, Louise Linsell, Evelyne Jacqz-Aigrain, Emmanuel Roilides, and Mike Sharland. "An Optimised Dosing Regimen Versus a Standard Dosing Regimen of Vancomycin for the Treatment of Late Onset Sepsis Due to Gram-positive Microorganisms in Neonates and Infants Aged Less Than 90 days (NeoVanc): Study Protocol for a Randomised Controlled Trial." Trials 2020.

Hill, Louise F., et al. "An Optimised Dosing Regimen Versus a Standard Dosing Regimen of Vancomycin for the Treatment of Late Onset Sepsis Due to Gram-positive Microorganisms in Neonates and Infants Aged Less Than 90 days (NeoVanc): Study Protocol for a Randomised Controlled Trial." Trials 2020.